Coexpression cluster:C446: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
|gostat_on_coexpression_clusters=GO:0005515!protein binding!0.0198265617681682!79890;7128;9693;55534;9586;5023;2353$GO:0006366!transcription from RNA polymerase II promoter!0.0222516553977654!55534;9586;2353$GO:0065007!biological regulation!0.0222516553977654!7128;9693;55534;9586;5023;2353$GO:0017034!Rap guanyl-nucleotide exchange factor activity!0.0222516553977654!9693$GO:0046582!Rap GTPase activator activity!0.023800322236145!9693$GO:0004931!ATP-gated cation channel activity!0.023800322236145!5023$GO:0035249!synaptic transmission, glutamatergic!0.023800322236145!5023$GO:0045893!positive regulation of transcription, DNA-dependent!0.023800322236145!55534;9586$GO:0043124!negative regulation of I-kappaB kinase/NF-kappaB cascade!0.0265035690185179!7128$GO:0007165!signal transduction!0.0265035690185179!79890;7128;9693;55534;5023$GO:0045941!positive regulation of transcription!0.0265035690185179!55534;9586$GO:0045935!positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process!0.0265035690185179!55534;9586$GO:0007154!cell communication!0.0296771541767025!79890;7128;9693;55534;5023$GO:0050794!regulation of cellular process!0.0296771541767025!7128;9693;55534;9586;2353$GO:0005096!GTPase activator activity!0.0296771541767025!79890;9693$GO:0031325!positive regulation of cellular metabolic process!0.0296771541767025!55534;9586$GO:0046983!protein dimerization activity!0.0296771541767025!9586;2353$GO:0007243!protein kinase cascade!0.0296771541767025!7128;9693$GO:0009893!positive regulation of metabolic process!0.0303613989977837!55534;9586$GO:0050789!regulation of biological process!0.0315500390975979!7128;9693;55534;9586;2353$GO:0006357!regulation of transcription from RNA polymerase II promoter!0.0320551948780199!55534;2353$GO:0042310!vasoconstriction!0.0323260544063619!5023$GO:0044451!nucleoplasm part!0.0323557424108025!55534;2353$GO:0008047!enzyme activator activity!0.0323557424108025!79890;9693$GO:0007270!nerve-nerve synaptic transmission!0.0337717794615979!5023$GO:0005654!nucleoplasm!0.0364885636811877!55534;2353$GO:0006305!DNA alkylation!0.0364885636811877!2353$GO:0006306!DNA methylation!0.0364885636811877!2353$GO:0006304!DNA modification!0.0428701763320134!2353 | |gostat_on_coexpression_clusters=GO:0005515!protein binding!0.0198265617681682!79890;7128;9693;55534;9586;5023;2353$GO:0006366!transcription from RNA polymerase II promoter!0.0222516553977654!55534;9586;2353$GO:0065007!biological regulation!0.0222516553977654!7128;9693;55534;9586;5023;2353$GO:0017034!Rap guanyl-nucleotide exchange factor activity!0.0222516553977654!9693$GO:0046582!Rap GTPase activator activity!0.023800322236145!9693$GO:0004931!ATP-gated cation channel activity!0.023800322236145!5023$GO:0035249!synaptic transmission, glutamatergic!0.023800322236145!5023$GO:0045893!positive regulation of transcription, DNA-dependent!0.023800322236145!55534;9586$GO:0043124!negative regulation of I-kappaB kinase/NF-kappaB cascade!0.0265035690185179!7128$GO:0007165!signal transduction!0.0265035690185179!79890;7128;9693;55534;5023$GO:0045941!positive regulation of transcription!0.0265035690185179!55534;9586$GO:0045935!positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process!0.0265035690185179!55534;9586$GO:0007154!cell communication!0.0296771541767025!79890;7128;9693;55534;5023$GO:0050794!regulation of cellular process!0.0296771541767025!7128;9693;55534;9586;2353$GO:0005096!GTPase activator activity!0.0296771541767025!79890;9693$GO:0031325!positive regulation of cellular metabolic process!0.0296771541767025!55534;9586$GO:0046983!protein dimerization activity!0.0296771541767025!9586;2353$GO:0007243!protein kinase cascade!0.0296771541767025!7128;9693$GO:0009893!positive regulation of metabolic process!0.0303613989977837!55534;9586$GO:0050789!regulation of biological process!0.0315500390975979!7128;9693;55534;9586;2353$GO:0006357!regulation of transcription from RNA polymerase II promoter!0.0320551948780199!55534;2353$GO:0042310!vasoconstriction!0.0323260544063619!5023$GO:0044451!nucleoplasm part!0.0323557424108025!55534;2353$GO:0008047!enzyme activator activity!0.0323557424108025!79890;9693$GO:0007270!nerve-nerve synaptic transmission!0.0337717794615979!5023$GO:0005654!nucleoplasm!0.0364885636811877!55534;2353$GO:0006305!DNA alkylation!0.0364885636811877!2353$GO:0006306!DNA methylation!0.0364885636811877!2353$GO:0006304!DNA modification!0.0428701763320134!2353 | ||
|id=C446 | |id=C446 | ||
|ontology_enrichment_celltype=CL:0000766!1.02e-26!76;CL:0002057!3.71e-26!42;CL:0000557!4.08e-23!71;CL:0000763!2.79e-22!112;CL:0000049!2.79e-22!112;CL:0000860!2.37e-21!45;CL:0000839!6.45e-21!70;CL:0002009!1.18e-19!65;CL:0002194!1.09e-18!63;CL:0000576!1.09e-18!63;CL:0000040!1.09e-18!63;CL:0000559!1.09e-18!63;CL:0000738!2.52e-18!140;CL:0000037!4.65e-18!172;CL:0000566!4.65e-18!172;CL:0002032!2.50e-16!165;CL:0000837!2.50e-16!165;CL:0000988!3.77e-16!182;CL:0002031!2.10e-14!124;CL:0002087!1.84e-12!119;CL:0000094!7.87e-07!8 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_uberon=UBERON:0007023!3.97e-29!115;UBERON:0002390!6.66e-26!102;UBERON:0003061!6.66e-26!102;UBERON:0002193!1.94e-25!112;UBERON:0002371!4.82e-20!80;UBERON:0001474!4.79e-19!86;UBERON:0004765!1.24e-15!101;UBERON:0001434!1.24e-15!101;UBERON:0002405!2.45e-13!115;UBERON:0003081!2.15e-11!216;UBERON:0001049!1.26e-10!57;UBERON:0005068!1.26e-10!57;UBERON:0006241!1.26e-10!57;UBERON:0007135!1.26e-10!57;UBERON:0003080!5.89e-09!42;UBERON:0002780!1.10e-08!41;UBERON:0001890!1.10e-08!41;UBERON:0006240!1.10e-08!41;UBERON:0002616!1.27e-08!59;UBERON:0002020!4.04e-08!34;UBERON:0003528!4.04e-08!34;UBERON:0001017!4.30e-08!82;UBERON:0001893!4.81e-08!34;UBERON:0002791!8.14e-08!33;UBERON:0001869!1.66e-07!32;UBERON:0005743!1.84e-07!86;UBERON:0000178!3.30e-07!15;UBERON:0000179!3.30e-07!15;UBERON:0000463!3.30e-07!15;UBERON:0000955!3.56e-07!69;UBERON:0006238!3.56e-07!69;UBERON:0002619!7.41e-07!22 | |||
}} | }} |
Revision as of 14:48, 21 May 2012
Full id: C446_Neutrophils_Mast_Eosinophils_Whole_CD14_immature_optic
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005515 | protein binding | 0.0198265617681682 |
GO:0006366 | transcription from RNA polymerase II promoter | 0.0222516553977654 |
GO:0065007 | biological regulation | 0.0222516553977654 |
GO:0017034 | Rap guanyl-nucleotide exchange factor activity | 0.0222516553977654 |
GO:0046582 | Rap GTPase activator activity | 0.023800322236145 |
GO:0004931 | ATP-gated cation channel activity | 0.023800322236145 |
GO:0035249 | synaptic transmission, glutamatergic | 0.023800322236145 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.023800322236145 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB cascade | 0.0265035690185179 |
GO:0007165 | signal transduction | 0.0265035690185179 |
GO:0045941 | positive regulation of transcription | 0.0265035690185179 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0265035690185179 |
GO:0007154 | cell communication | 0.0296771541767025 |
GO:0050794 | regulation of cellular process | 0.0296771541767025 |
GO:0005096 | GTPase activator activity | 0.0296771541767025 |
GO:0031325 | positive regulation of cellular metabolic process | 0.0296771541767025 |
GO:0046983 | protein dimerization activity | 0.0296771541767025 |
GO:0007243 | protein kinase cascade | 0.0296771541767025 |
GO:0009893 | positive regulation of metabolic process | 0.0303613989977837 |
GO:0050789 | regulation of biological process | 0.0315500390975979 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 0.0320551948780199 |
GO:0042310 | vasoconstriction | 0.0323260544063619 |
GO:0044451 | nucleoplasm part | 0.0323557424108025 |
GO:0008047 | enzyme activator activity | 0.0323557424108025 |
GO:0007270 | nerve-nerve synaptic transmission | 0.0337717794615979 |
GO:0005654 | nucleoplasm | 0.0364885636811877 |
GO:0006305 | DNA alkylation | 0.0364885636811877 |
GO:0006306 | DNA methylation | 0.0364885636811877 |
GO:0006304 | DNA modification | 0.0428701763320134 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
myeloid leukocyte | 1.02e-26 | 76 |
CD14-positive, CD16-negative classical monocyte | 3.71e-26 | 42 |
granulocyte monocyte progenitor cell | 4.08e-23 | 71 |
myeloid cell | 2.79e-22 | 112 |
common myeloid progenitor | 2.79e-22 | 112 |
classical monocyte | 2.37e-21 | 45 |
myeloid lineage restricted progenitor cell | 6.45e-21 | 70 |
macrophage dendritic cell progenitor | 1.18e-19 | 65 |
monopoietic cell | 1.09e-18 | 63 |
monocyte | 1.09e-18 | 63 |
monoblast | 1.09e-18 | 63 |
promonocyte | 1.09e-18 | 63 |
leukocyte | 2.52e-18 | 140 |
hematopoietic stem cell | 4.65e-18 | 172 |
angioblastic mesenchymal cell | 4.65e-18 | 172 |
hematopoietic oligopotent progenitor cell | 2.50e-16 | 165 |
hematopoietic multipotent progenitor cell | 2.50e-16 | 165 |
hematopoietic cell | 3.77e-16 | 182 |
hematopoietic lineage restricted progenitor cell | 2.10e-14 | 124 |
nongranular leukocyte | 1.84e-12 | 119 |
granulocyte | 7.87e-07 | 8 |
Ontology term | p-value | n |
---|---|---|
adult organism | 3.97e-29 | 115 |
hematopoietic system | 6.66e-26 | 102 |
blood island | 6.66e-26 | 102 |
hemolymphoid system | 1.94e-25 | 112 |
bone marrow | 4.82e-20 | 80 |
bone element | 4.79e-19 | 86 |
skeletal element | 1.24e-15 | 101 |
skeletal system | 1.24e-15 | 101 |
immune system | 2.45e-13 | 115 |
lateral plate mesoderm | 2.15e-11 | 216 |
neural tube | 1.26e-10 | 57 |
neural rod | 1.26e-10 | 57 |
future spinal cord | 1.26e-10 | 57 |
neural keel | 1.26e-10 | 57 |
anterior neural tube | 5.89e-09 | 42 |
regional part of forebrain | 1.10e-08 | 41 |
forebrain | 1.10e-08 | 41 |
future forebrain | 1.10e-08 | 41 |
regional part of brain | 1.27e-08 | 59 |
gray matter | 4.04e-08 | 34 |
brain grey matter | 4.04e-08 | 34 |
central nervous system | 4.30e-08 | 82 |
telencephalon | 4.81e-08 | 34 |
regional part of telencephalon | 8.14e-08 | 33 |
cerebral hemisphere | 1.66e-07 | 32 |
blood | 3.30e-07 | 15 |
haemolymphatic fluid | 3.30e-07 | 15 |
organism substance | 3.30e-07 | 15 |
brain | 3.56e-07 | 69 |
future brain | 3.56e-07 | 69 |
regional part of cerebral cortex | 7.41e-07 | 22 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.